Stock listing

Stoke Therapeutics, Inc.

Selected listing: STOK · NASDAQ · USD · US

Stoke Therapeutics, Inc. (NASDAQ:STOK), Health Technology. Latest release Oct 6, 2026: Stoke Therapeutics Announces Presentations of STK-002…

STOK:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:STOK
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. is a public company traded under the ticker STOK in the American market. Their approach aims to enhance protein production to address underlying causes of these conditions.

Latest news from Stoke Therapeutics, Inc.

Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting

October 5, 2026

Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome

October 4, 2026

Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome

October 5, 2026

Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization

September 23, 2026

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

September 1, 2026

All Stoke Therapeutics, Inc. news →

Events

Replays

Stoke Therapeutics, Inc. (STOK) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 04:30 PM ET
Watch
Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Stoke Therapeutics, Inc. (STOK) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 04:30 PM ET
Watch

Research Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. company profile

View the public company page for Stoke Therapeutics, Inc. on 6ix.

Stoke Therapeutics, Inc. news

Read company news and market updates connected to Stoke Therapeutics, Inc..

Stoke Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Stoke Therapeutics, Inc..